Passive or active delivery devices in diabetes administration?

Anecdotal evidence came to the attention of MindMetre Research regarding instances of mis-dosage or non-delivery of insulin to patients when passive devices were being used. The organisation decided to investigate whether this anecdotal evidence was also being experienced by a significant number of NHS Trusts. An enquiry was launched under the terms of the Freedom of Information Act (2000). The resulting evidence revealed: around one third of Trusts were experiencing this phenomenon; a significant proportion of Trusts either gave indefinite answers to the questions posed or were unable to answer the questions; and a handful of Trusts reported that they had switched from passive to active delivery devices because of concerns over patient well-being and the avoidance of mis-dosage.